---
title: "Doyle Mittie — Ownership Dossier"
canonical: https://whiteintel.dev/entity/64e33ea8-41a3-5d8a-90de-708e426a2093
json: https://whiteintel.dev/api/public/dossier/64e33ea8-41a3-5d8a-90de-708e426a2093
identifier: sec:0001918845
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Doyle Mittie

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001918845`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/64e33ea8-41a3-5d8a-90de-708e426a2093  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/64e33ea8-41a3-5d8a-90de-708e426a2093  

## Ownership & control

### Holdings / subsidiaries

- **Avalo Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/7ab53ad5-4202-5e5d-afb7-054c499320ac
- **Cullinan Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/e103e223-6420-5795-bce5-450261fac1da
- **Avalo Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/7ab53ad5-4202-5e5d-afb7-054c499320ac
- **DICE MOLECULES HOLDINGS, LLC** (director) — https://whiteintel.dev/entity/998fcfd9-2558-57b2-8535-15ce70c8b5da

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Doyle Mittie**. Human view: https://whiteintel.dev/entity/64e33ea8-41a3-5d8a-90de-708e426a2093 · Structured JSON: https://whiteintel.dev/api/public/dossier/64e33ea8-41a3-5d8a-90de-708e426a2093._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._